Neighborhood-Level Socioeconomics Tied to MS Disability Progression
Lower neighborhood-level socioeconomic status (SES) is associated with a higher risk for disability progression in patients with multiple sclerosis.
Multiple Sclerosis
Examining the Incidence of Immune Thrombocytopenia in Alemtuzumab Treatment for MS
The majority of treatment-related cases of immune thrombocytopenia can be remedied with the use of corticosteroids, platelets, or intravenous immunoglobulin.
Does Socioeconomic Status Affect Disability Progression in MS?
Socioeconomic status has been linked to an elevated risk for disease progression in MS.
NAIMS Summary on Emerging Techniques to Assess Neuroprotection and Repair in MS
Based on the collective opinion of the NAIMS Cooperative, there are a number of promising MRI techniques with different strengths and limitations to accelerate the discovery of effective treatments for all stages of multiple sclerosis.
AAN: No Increased MS Relapse Risk in Postpartum Period
Women with multiple sclerosis seem not to suffer from pregnancy-related relapses in the early postpartum period.
Prevalence of MS Increased Substantially From 1990 to 2016
Regions with the highest age-standardized multiple sclerosis prevalence estimates per 100,000 population included high-income North America, Western Europe, and Australasia.
Case Study: Headaches, Double Vision, and Tingling Extremities in a Young Woman
A 19-year-old woman with a history of migraine headaches initially presented with subacute onset of double vision and vertigo.The following case study was provided by Daniel Ontaneda, MD, and Marisa McGinley, DO, both neurologists at the Cleveland Clinic in Ohio. In addition, Dr Ontaneda is a co-primary investigator of the international Determining the Effectiveness of…
Managing Anxiety, Depression in Multiple Sclerosis Key to Mitigating Cognitive Effects of Disease
The management of symptoms of anxiety and of depression in patients with MS is key to mitigating their effect on cognition and functioning.
Atorvastatin Associated With Milder Disease Progression in Relapsing-Remitting Multiple Sclerosis
No significant associations were found between atorvastatin treatment and time to first relapse.
Contributors to Delay of Multiple Sclerosis Diagnosis ID’d
First symptoms and disease type are contributors to delays in multiple sclerosis diagnosis.
Next post in Multiple Sclerosis
